Skip to main content

Table 1 Publications on CO-MRSA infections in Australia used to calculate incidences in this study

From: Incidence of community onset MRSA in Australia: least reported where it is Most prevalent

Citation

Regiona

Data collection period

Admission status

Site of infectionb

Data source(s)c

Additional exclusionsd

Publication typee

Nimmo 2013 [13]

Queensland

2011

IP,OP,ED

All

P,D

T

PRJ

Stevens 2006 [28]

Alice Springs, NT

2005–6

IP,OP,ED

All

R,D

T

PRJ

Agostino 2016 [20]

Hunter - New England, NSW

2008–14

IP,OP,ED

Total

R

T

Th

Mitchell 2009 [46]

Tasmania

2008–9

IP,OP,ED

Total

S

s,c,p,d,t

GR

Tong 2009 [15]

Top End, NT

2006–7

IP,ED

Total

P

t,Other

PRJ

Wehrhahn 2010 [8]

Perth – Fremantle, WA

2005–7

IP

All

P

s,c,p,d,o,t

PRJ

Bennett 2007 [34]

Small hospitals Victoria

2004–5

IP

Total

S

T

PRJ

Marquess 2013 [35]

Queensland

2005–2010

IP

BSI

R

NS

PRJ

Robinson 2009 [19]

Perth, WA

1997–2007

IP

BSI

R

t,Other

PRJ

Laupland 2013 [33]

ACT

2000–8

IP

BSI

NS

NS

PRJ

Strachan 2014 [18]

Victoria

2009–13

IP

BSI

S

–

GR

Wells 2014 [32]

Tasmania

2008–14

IP

BSI

S

s,c,p,d,t

GR

Tong 2015 [17]

Northern Territory

2008–12

OP

SSTI

C

NS

PRJ

Bennett 2014 [36]

Melbourne, Vic

2006

OP

SSTI

C

L,t

PRJ

Pandey 2008 [39]

Bowral, NSW

2004

ED

SSTI

NS

NS

LE

Lim 2014 [40]

The Alfred Hospital, Vic

2003–11

ED

BSI

NS

m,t

PRJ

  1. aAustralian Capital Territory (ACT), Victoria (Vic)
  2. bAll: data for SSTIs, LRTIs, BSIs and others listed separately, Total: only data for total infections were provided
  3. cR: retrospective review of laboratory database, P: prospectively identified cases for inclusion, C: Community pathology database, S: surveillance system, D: discharge diagnosis, NS: not stated
  4. d s: surgical procedure – some authors required that the infection was at the surgical site c: therapy for cancer (variously: receiving IV chemotherapy, being an oncology patient, neutropenia or immunosuppressive medication), p: percutaneous or indwelling device, d: dialysis, t: time since previous discharge (variously ≤48 h to ≤12 months), L: residence in long term care facility, m: children (either less than 18 or 20 years old), o: other, NS: none stated. Further exclusion criteria included history of S. aureus infection, being an intravenous drug user, organ transplant recipients, respiratory and burns patients, receiving plasmapheresis, home IV therapy or employment in healthcare
  5. e PRJ peer-reviewed academic article, Th thesis, GR government report, LE letter to the editor